Meeting Banner
Abstract #4210

Diagnostic Performance of Gd-EOB-DTPA for Hepatocellular Carcinoma Based on LI-RADS v2018, Compared With v2017

Fei Xing1 and Xiance Zhao2
1the Third People’s Hospital of Nantong, Nantong, China, 2Philips Healthcare, Shanghai, China


The purpose of this study was to compare the diagnostic performance of the LI-RADS v2017 and v2018 for HCC in patients with cirrhosis using Gd-EOB-DTPA. We retrospectively analyzed Clinical data of 213 patients(246 observations)with cirrhosis who underwent Gd-EOB-DTPA from October 2015 to July 2020 were retrospectively collected. MRI major features were reviewed by two radiologists. The LI-RADS categories were assigned according to v2017 and v2018. Our study showed that Updated LR-5 criteria on Gd-EOB-DTPA, the diagnostic performance of LI-RADS v2018 for diagnosing HCC is superior to v2017, particularly in small HCC (10–19 mm), with a greater sensitivity and similar specificity.

This abstract and the presentation materials are available to members only; a login is required.

Join Here